Madrigal Pharma CEO talks competition in the GLP-1 space and new drug rollouts

Bill Sibold, Madrigal Pharma CEO, joins 'Fast Money' to talk GLP-1 drug competition, its liver disease treatment, its Mash drug rollout and more.

Related Posts

We developed 'best in class' enterprise travel expense ...

admin Oct 16, 2024  0  9

Dutch Bros. CEO Christine Barone goes one-on-one with J...

admin Aug 9, 2024  0  7

Cato CEO on the future of cybersecurity

admin Jul 30, 2024  0  16

Comments

Name

Email

Comment

Post Comment